Ultrafiltration

Nuwellis Announces Launch of Ultrafiltration Therapy Using Aquadex Smartflow® System at Henry Ford Health

Retrieved on: 
Tuesday, April 9, 2024
Ultrafiltration, Diuretic, Trial of the century, Henry Ford, Patient, Heart failure, The Henry Ford, Pharmaceutical industry

MINNEAPOLIS, April 09, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE) today announced that Detroit, Michigan-based health system, Henry Ford Health, has begun offering ultrafiltration therapy to heart failure patients suffering from fluid overload using the company’s Aquadex SmartFlow system as part of Nuwellis’ pivotal REVERSE-HF clinical study.

Key Points: 
  • MINNEAPOLIS, April 09, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE) today announced that Detroit, Michigan-based health system, Henry Ford Health, has begun offering ultrafiltration therapy to heart failure patients suffering from fluid overload using the company’s Aquadex SmartFlow system as part of Nuwellis’ pivotal REVERSE-HF clinical study.
  • “We are excited to study the impact of Aquadex SmartFlow therapy on our heart failure patients who are suffering from severe fluid overload,” said Dr. Jennifer Cowger, Section Head of the heart failure program at Henry Ford.
  • “We are eager to see if ultrafiltration can affect clinical outcomes of our heart failure patients resistant to diuretics.
  • “We are proud and honored to be working with Henry Ford Health and look forward to partnering with Dr. Cowger and the team of heart failure experts through the REVERSE-HF trial.

Water and Wastewater Treatment Equipment Market worth $87.7 billion by 2029 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Tuesday, April 9, 2024
Carbon, Ultrafiltration, UV, Culligan, Urbanization, Growth, Recycling, IC, Filtration, Water pollution, Public, Electronics, Water quality, Water, Population growth, Disinfectant, Sewage treatment

The primary reason for the tertiary process segment's prominence in the water and wastewater treatment equipment market is its critical role in achieving stringent water quality standards.

Key Points: 
  • The primary reason for the tertiary process segment's prominence in the water and wastewater treatment equipment market is its critical role in achieving stringent water quality standards.
  • The filtration segment holds the top position in the water and wastewater treatment equipment market due to several pivotal reasons.
  • Firstly, filtration serves as a fundamental and indispensable process in water treatment procedures, regardless of the water source or type under treatment.
  • The dominance of the municipal segment in the water and wastewater treatment equipment market can be attributed to several pivotal factors.

Water and Wastewater Treatment Equipment Market worth $87.7 billion by 2029 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Tuesday, April 9, 2024
Carbon, Ultrafiltration, UV, Culligan, Urbanization, Growth, Recycling, IC, Filtration, Water pollution, Public, Electronics, Water quality, Water, Population growth, Disinfectant, Sewage treatment

The primary reason for the tertiary process segment's prominence in the water and wastewater treatment equipment market is its critical role in achieving stringent water quality standards.

Key Points: 
  • The primary reason for the tertiary process segment's prominence in the water and wastewater treatment equipment market is its critical role in achieving stringent water quality standards.
  • The filtration segment holds the top position in the water and wastewater treatment equipment market due to several pivotal reasons.
  • Firstly, filtration serves as a fundamental and indispensable process in water treatment procedures, regardless of the water source or type under treatment.
  • The dominance of the municipal segment in the water and wastewater treatment equipment market can be attributed to several pivotal factors.

H2O Innovation Awarded Eight New Water Treatment Projects, Including its Largest One to Date for the Los Angeles Sanitation and Environment

Retrieved on: 
Wednesday, April 3, 2024
Environment, Engineering, Utilities, Manufacturing, Sustainability, Green Technology, Energy, Other Natural Resources, Natural Resources, Ultrafiltration, Yellowstone River, UF, Demographics of Los Angeles, Corporation, City, Water, WTS, Seawater, MBR, Multimedia, Drinking water, Sewage treatment

H2O Innovation Inc. (“H2O Innovation” or the “Corporation”) is pleased to announce that its Water Technologies and Services (WTS) business line obtained eight new water treatment contracts over the past few months.

Key Points: 
  • H2O Innovation Inc. (“H2O Innovation” or the “Corporation”) is pleased to announce that its Water Technologies and Services (WTS) business line obtained eight new water treatment contracts over the past few months.
  • View the full release here: https://www.businesswire.com/news/home/20240403411653/en/
    The most significant of these new contracts is for the largest water reuse project in H2O Innovation’s history: Donald C. Tillman Advanced Water Purification Facility (AWPF).
  • This treatment system will apply ultrafiltration (UF) and reverse osmosis (RO) to provide reuse water for the City of Los Angeles, California.
  • A second major contract was executed with the City of Billings for their drinking water treatment plant in Montana.

CMUH(Taiwan) Using AI to Monitor Home Hemodialysis

Retrieved on: 
Monday, March 18, 2024
Ultrafiltration, Blood pressure, Osmotic pressure, Chronic kidney disease, Renal replacement therapy, Patient, Peritoneal dialysis, Home hemodialysis, Fatigue, AI, Quality of life, Dehydration, Water, Safety, Dialysis, Patient safety, Family, HHD, Work, Medical device

TAICHUNG, March 18, 2024 /PRNewswire/ -- Chronic Kidney Disease has become a new "national disease" in Taiwan, and the number of patients requiring hemodialysis is increasing. Traditionally, hemodialysis patients and accompanies require at least an hour spent on commuting, and that maybe even more time consuming for those who live in suburbs. Moreover, patients almost feel tired or fatigue and need rest half a day following hemodialysis. Since 2019 in Taiwan, China Medical University Hospital (CMUH) has initiated and implemented AI monitoring system for hemodialysis patients. The unique AI system receives the messages sent by the dialysis machine to keep track of any risk message with incorporated AI system, ensuring patient safety and collecting information for prescription adaptation. Accredited with CMUH's AI technology, those who require hemodialysis are not necessary to visit a healthcare facility for this routine. Dr. Huey-Liang Kuo, Director of Hemodialysis Center at CMUH, stated that patients have been heathier and safer to do hemodialysis at home.

Key Points: 
  • Since 2019 in Taiwan, China Medical University Hospital (CMUH) has initiated and implemented AI monitoring system for hemodialysis patients.
  • The unique AI system receives the messages sent by the dialysis machine to keep track of any risk message with incorporated AI system, ensuring patient safety and collecting information for prescription adaptation.
  • Accredited with CMUH's AI technology, those who require hemodialysis are not necessary to visit a healthcare facility for this routine.
  • Dr. Huey-Liang Kuo, Director of Hemodialysis Center at CMUH, stated that patients have been heathier and safer to do hemodialysis at home.

Late-Breaking Data Highlighting Benefits of Ultrafiltration Therapy Using the Aquadex System for Heart Failure Patients was Presented at the Technology and Heart Failure Therapeutics Conference

Retrieved on: 
Thursday, March 7, 2024
Diuretic, Ultrafiltration, Hospital, Section, Artificial intelligence, Randomized controlled trial, Mount Sinai Health System, Quality of life, Acute decompensated heart failure, Hierarchy, Aquapheresis, Valvular heart disease, Risk, Heart failure, Arrhythmia, AUF, ALD, History, Yale School of Medicine, Patient, HF, Machine learning, Cerebrovascular disease, THT, Mortality, Roflumilast, Pharmaceutical industry

MINNEAPOLIS, March 07, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on transforming the lives of people with fluid overload, announced results from two new clinical data analyses from the AVOID-HF trial, which demonstrate the benefits of its Aquadex System in reducing heart failure readmissions at 30 days. Results from the analyses were presented in a late-breaking session at the Technology and Heart Failure Therapeutics (THT) conference in Boston.

Key Points: 
  • Results from the analyses were presented in a late-breaking session at the Technology and Heart Failure Therapeutics (THT) conference in Boston.
  • Key findings demonstrating the benefits of AUF include:
    Fewer heart failure events and heart failure hospitalizations: AUF patients had significantly fewer heart failure events within 30 days compared to ALD (90% vs 77.3% p=0.0138) and fewer heart failure hospitalizations for the AUF patients compared to the ALD patients (90.0% vs. 79.2% p=0.0321) within 30 days.
  • Key findings from the analysis include:
    Top predictors for 90-day heart failure events: Using ML, the study identified the top 10 predictors for 90-day heart failure events.
  • Strong results for super-responders: 90% of patients categorized as super-responders to AUF therapy within this model did not experience any 90-day heart failure events.

Repligen Reports Fourth Quarter and Full Year 2023 Financial Results

Retrieved on: 
Wednesday, February 21, 2024
Acquisition, Filtration, Ultrafiltration, Growth, Loss, ESG, Cross-flow filtration, GAAP, Net, TFF, Repligen

WALTHAM, Mass., Feb. 21, 2024 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today reported financial results for its fourth quarter of 2023, covering the three- and twelve-month periods ended December 31, 2023.

Key Points: 
  • WALTHAM, Mass., Feb. 21, 2024 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today reported financial results for its fourth quarter of 2023, covering the three- and twelve-month periods ended December 31, 2023.
  • We are pleased to report that for the second quarter in a row, our book-to-bill ratio was above 1.0, at 1.03 for the fourth quarter.
  • Base revenue (non-GAAP) for Q4 2023 was $142.1 million, compared to $163.0 million for Q4 2022.
  • For Q4 2023, net loss (GAAP) was ($25.5) million, compared to net income (GAAP) of $48.7 million for Q4 2022.

Nuwellis to Announce Late-Breaking Clinical Data and Host Satellite Symposium at Technology and Heart Failure Therapeutics Conference

Retrieved on: 
Tuesday, February 20, 2024
Artificial intelligence, CRF, Heart failure, Ultrafiltration, Therapy, Health, Machine learning, THT, Pharmaceutical industry

MINNEAPOLIS, Feb. 20, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on transforming the lives of people with fluid overload, today announced its planned activities at the upcoming Technology and Heart Failure Therapeutics conference (THT 2024), which is produced by the Cardiovascular Research Foundation (CRF), taking place March 4-6, in Boston.

Key Points: 
  • MINNEAPOLIS, Feb. 20, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on transforming the lives of people with fluid overload, today announced its planned activities at the upcoming Technology and Heart Failure Therapeutics conference (THT 2024), which is produced by the Cardiovascular Research Foundation (CRF), taking place March 4-6, in Boston.
  • Nuwellis will exhibit at booth #8, host a sponsored satellite symposium and highlight two late-breaking clinical abstracts during the conference.
  • Events where Nuwellis and its Aquadex SmartFlow® System will be featured at THT 2024 include:
    Title: Aquapheresis for Management of Decompensated Heart Failure: A Re-appraisal of AVOID-HF
    Title: AI Assisted Identification of Super responders for Ultrafiltration can Reduce 90-Day Readmission Rates: Evidence from AVOID-HF Trial
    THT is a premier destination for pioneering data and comprehensive updates on heart failure treatments using medical technology.
  • The conference provides a forward-looking view of the heart failure therapeutics pipeline, delving into the role of emerging technologies like artificial intelligence and machine learning in heart failure patient care.

Recycling Water Filtration Market worth $3.8 billion by 2028 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Thursday, February 15, 2024
Filtration, Ultrafiltration, Kubota, Filter press, Filter paper, Cartridge, Investment, Pulp and Paper, Nonwoven fabric, Recycling, HEPA, Urbanization, Carbon, Atmosphere of Earth, Activated carbon, Metal, Bacteria, Water, Virus, ULPA, Coalescer, Fiberglass, Population growth, Membrane, Sewage treatment

Based on product type, the Recycling Water Filtration Market has been segmented into sand filters, multimedia filters, activated carbon filters, and membrane filters.

Key Points: 
  • Based on product type, the Recycling Water Filtration Market has been segmented into sand filters, multimedia filters, activated carbon filters, and membrane filters.
  • This report segments the Recycling Water Filtration Market based on membrane type into ultrafiltration, nanofiltration, microfiltration and reverse osmosis.
  • Asia Pacific is expected to be the largest Recycling Water Filtration Market during the forecast period.
  • The Recycling Water Filtration Market is flourishing in the Asia Pacific due to the pressing need for sustainable water management.

Recycling Water Filtration Market worth $3.8 billion by 2028 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Thursday, February 15, 2024
Filtration, Ultrafiltration, Kubota, Filter press, Filter paper, Cartridge, Investment, Pulp and Paper, Nonwoven fabric, Recycling, HEPA, Urbanization, Carbon, Atmosphere of Earth, Activated carbon, Metal, Bacteria, Water, Virus, ULPA, Coalescer, Fiberglass, Population growth, Membrane, Sewage treatment

Based on product type, the Recycling Water Filtration Market has been segmented into sand filters, multimedia filters, activated carbon filters, and membrane filters.

Key Points: 
  • Based on product type, the Recycling Water Filtration Market has been segmented into sand filters, multimedia filters, activated carbon filters, and membrane filters.
  • This report segments the Recycling Water Filtration Market based on membrane type into ultrafiltration, nanofiltration, microfiltration and reverse osmosis.
  • Asia Pacific is expected to be the largest Recycling Water Filtration Market during the forecast period.
  • The Recycling Water Filtration Market is flourishing in the Asia Pacific due to the pressing need for sustainable water management.